Drive to Deprescribe: Sharing Key Strategies and Successes (November 2021)
Recorded On: 11/18/2021
-
Register
- Non-member - Free!
- Member - Free!
The issue of polypharmacy and inappropriate medication use in post-acute and long-term care (PALTC) has been an ongoing concern. The PALTC setting has one of the highest polypharmacy rates, which increases the risk for adverse events and drug interactions.
Since May 2021, PALTmed and ASCP have been holding meetings and developing resources to help prescribers, pharmacists, DONs, CNOs, CMOs, and CEOs optimize medication use in the long-term care setting. This is the recording of this topic's session.
For more information and additional resources, visit paltmed.org/drive-deprescribe.
Michael Cinque, PharmD, FAPhA
Michael Cinque PharmD, FAPhA, currently serves as the Senior Vice President of Clinical Strategic Partnerships at InnovAge and operates as a consultant in Medication Use Management through Michael Cinque Consulting. Prior experience includes a role as Senior Vice President of Pharmacy Management at Genesis and as President at Enclara Pharmacia, where notable achievements included driving the integration of Enclara Pharmacia with Hospice Pharmacia. Previously, Michael Cinque held positions such as Vice President of Operations at Hospice Pharmacia, overseeing a substantial payroll and managing extensive operations, and Chief Pharmaceutical Care Officer at excelleRx Hospice Pharmacia, where responsibilities included leading clinical operations. Academic credentials consist of a Bachelor of Science in Pharmacy from Temple University School of Pharmacy and a Doctor of Pharmacy degree from the University of Florida.
Toni Clarke, MSN, APRN, AGNP-C, HCS-D
David Greenberg, MD
Teal Hutzler, FNP-ANCC
This course is not for credit.
